nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfacetamide—Lupus erythematosus—Methoxsalen—vitiligo	0.323	0.323	CcSEcCtD
Sulfacetamide—Systemic lupus erythematosus—Methoxsalen—vitiligo	0.218	0.218	CcSEcCtD
Sulfacetamide—Blister—Methoxsalen—vitiligo	0.167	0.167	CcSEcCtD
Sulfacetamide—Dermatitis bullous—Methoxsalen—vitiligo	0.0915	0.0915	CcSEcCtD
Sulfacetamide—Erythema—Methoxsalen—vitiligo	0.0527	0.0527	CcSEcCtD
Sulfacetamide—Oedema—Methoxsalen—vitiligo	0.043	0.043	CcSEcCtD
Sulfacetamide—Infection—Methoxsalen—vitiligo	0.0427	0.0427	CcSEcCtD
Sulfacetamide—Hypersensitivity—Methoxsalen—vitiligo	0.0317	0.0317	CcSEcCtD
Sulfacetamide—Pruritus—Methoxsalen—vitiligo	0.0304	0.0304	CcSEcCtD
